Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2863556 | The American Journal of the Medical Sciences | 2012 | 7 Pages |
Abstract
Knockdown of survivin expression enhanced sensitivity of gastric cancer cells to radiation, cisplatin and 5-FU treatment in vitro and in nude mice. These results demonstrate that clinical trails are warranted of survivin shRNA as an adjuvant therapy for gastric cancer patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Xin MD, PhD, Jian-yong MD, Hai MD, PhD, Zhang MD, PhD, Wei-zhong PhD,